0001209191-22-055325.txt : 20221102 0001209191-22-055325.hdr.sgml : 20221102 20221102164014 ACCESSION NUMBER: 0001209191-22-055325 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221101 FILED AS OF DATE: 20221102 DATE AS OF CHANGE: 20221102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harbin Stephen CENTRAL INDEX KEY: 0001835251 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39575 FILM NUMBER: 221354747 MAIL ADDRESS: STREET 1: C/O ONCORUS, INC. STREET 2: 50 HAMPSHIRE STREET, SUITE 401 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncorus, Inc. CENTRAL INDEX KEY: 0001671818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473779757 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4 CORPORATE DRIVE CITY: ANDOVER STATE: MA ZIP: 01810 BUSINESS PHONE: 857-320-6400 MAIL ADDRESS: STREET 1: 4 CORPORATE DRIVE CITY: ANDOVER STATE: MA ZIP: 01810 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-01 0 0001671818 Oncorus, Inc. ONCR 0001835251 Harbin Stephen C/O ONCORUS, INC. 4 CORPORATE DRIVE ANDOVER MA 01810 0 1 0 0 COO and Chief of Staff Stock Option (right to buy) 0.67 2022-11-01 4 A 0 150000 0.00 A 2032-11-01 Common Stock 150000 150000 D The option shall vest as to 50% of the underlying shares on March 31, 2023, and as to the remaining 50% of the underlying shares on December 31, 2023, subject to the Reporting Person continuing to provide service through each such date. /s/ Brian J. Shea, Attorney-in-Fact 2022-11-02